A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61K 31/22 (2006.01) A61K 31/365 (2006.01) A61K 31/40 (2006.01) A61K 31/44 (2006.01) A61K 31/4747 (2006.01) A61K 31/585 (2006.01)
Patent
CA 2452678
Novel methods and combinations for the treatment and/or prophylaxis of a pathologic condition in a subject, wherein the methods comprise the administration of one or more HMG Co-A reductase inhibitors and one or more aldosterone receptor antagonists, and the combinations comprise one or more HMG Co-A reductase inhibitors and one or more of said aldosterone receptor antagonists.
L'invention concerne des nouveaux procédés et de nouvelles combinaisons destinés au traitement et/ou à la prophylaxie d'une condition pathologique chez un sujet. Ce procédé comprend l'administration de un ou plusieurs inhibiteurs de réductase d'HMG Co-A et de un ou plusieurs antagonistes de récepteur d'aldostérone. Ces combinaisons comportent un ou plusieurs inhibiteurs de réductase HMG Co-A et un ou plusieurs antagonistes de récepteur d'aldostérone.
Keller Bradley T.
Mcmahon Ellen G.
Rocha Ricardo
Pharmacia Corporation
Sim & Mcburney
LandOfFree
Combination of eplerenone and an hmg coa reductase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of eplerenone and an hmg coa reductase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of eplerenone and an hmg coa reductase inhibitor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1546869